Advertisement

Topics

Takeda Strikes $62B Deal to Acquire Rare Disease Drug Maker Shire

09:42 EDT 8 May 2018 | Xconomy

Takeda Pharmaceutical has reached an agreement to acquire Shire after raising its offer for the rare disease drug company. Under the cash and stock agreement, Osaka, Japan-based Takeda will pay $30.33 in cash for each share of Shire (NASDAQ: SHPG). Shire shareholders will also receive 0.839 new Takeda shares or 1.678 Takeda American Depository Shares, […]

Original Article: Takeda Strikes $62B Deal to Acquire Rare Disease Drug Maker Shire

NEXT ARTICLE

More From BioPortfolio on "Takeda Strikes $62B Deal to Acquire Rare Disease Drug Maker Shire"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...